Nonbilharzial Squamous Cell Carcinoma and Transitional Cell Carcinoma with Squamous Differentiation of the Lower and Upper Urinary Tract

Overview

Journal Urol Ann

Specialty Urology

Date 2012 Feb 21

PMID 22346095

Citations 10

Authors

Steffen Rausch

Rainer Hofmann

Rolf von Knobloch

Affiliations

Soon will be listed here.

Abstract

Introduction: Urinary tract squamous cell carcinoma and transitional cell carcinoma with squamous differentiation are rare entities. To characterize tumour biology, prognosis, and therapy, we reviewed our data with squamous cell carcinoma (SCC) and transitional cell carcinoma (TCC/SCC).

Materials And Methods: We performed a retrospective single-center analysis of 53 patients with SCC and TCC/SCC treated at our urology department from 30.05.1989 to 30.09.2004.

Results: SCC was found in 2% (42/1573) of bladder carcinoma and 7% (11/130) of renal pelvis specimen. Stage pT3 was present in 55% of our patients, indicating a tendency to deep muscular invasion. Nodal and distant metastases appeared in 26%. The overall 5-year survival rate was 26% (tumor specific 46%), with a median survival of 10.5 months. We found that three of four patients with pT2N0 bladder carcinoma could be cured by cystectomy. Lymphnode status was identified as a significant prognostic parameter. For renal pelvis carcinoma, median survival was 7.35 months, with an overall 5-year-survival of 30%. Adjuvant therapy modalities were only performed in a minority of cases, although a therapeutic response was often noticed.

Conclusions: SCC is characterized by poor prognosis and individual tumor biology. Survival is related to local tumor extension, indicating the necessity of an early radical surgery. To adequately discuss the role of adjuvant therapy on SCC and TCC/SCC further trials are needed.

Citing Articles

Hypercalcemia-leukocytosis syndrome from non-schistosomiasis-associated squamous cell carcinoma of the urinary bladder: a case report and review of the literature.

Chibuzo I, Healy R, Hatimy U, Tang V J Med Case Rep. 2023; 17(1):133.

PMID: 37041610 PMC: 10091549. DOI: 10.1186/s13256-023-03860-x.

Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer.

Jung M, Rose M, Knuechel R, Loeffler C, Muti H, Kather J BMC Cancer. 2023; 23(1):113.

PMID: 36726072 PMC: 9890720. DOI: 10.1186/s12885-023-10576-0.

A case report of complete pathological remission after chemotherapy in a patient with primary renal squamous cell carcinoma.

Yu H, Yu L, Li J, Wang Y, Liu L, Zhang X Transl Androl Urol. 2021; 10(2):997-1005.

PMID: 33718101 PMC: 7947427. DOI: 10.21037/tau-20-1483.

Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study.

Rosiello G, Pecoraro A, Palumbo C, Knipper S, Luzzago S, Deuker M World J Urol. 2020; 39(3):813-822.

PMID: 32424515 DOI: 10.1007/s00345-020-03247-3.

Is survival after radical cystectomy for bladder cancer in Saudi patients different from that of Western patients?.

Mokhtar A, Al M, Al W, Othman K, Kattan S, Al M Ann Saudi Med. 2017; 37(3):194-200.

PMID: 28578357 PMC: 6150585. DOI: 10.5144/0256-4947.2017.194.

References

Logothetis C, Johnson D, Chong C, Dexeus F, Ogden S, von Eschenbach A . Adjuvant chemotherapy of bladder cancer: a preliminary report. J Urol. 1988; 139(6):1207-11. DOI: 10.1016/s0022-5347(17)42861-8. View

Kassouf W, Spiess P, Siefker-Radtke A, Swanson D, Grossman H, Kamat A . Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience. Cancer. 2007; 110(4):764-9. DOI: 10.1002/cncr.22853. View

Wu R, Osman I, Wu X, Lu M, Zhang Z, Liang F . Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation. Cancer Res. 1998; 58(6):1291-7. View

Huncharek M, Muscat J, Geschwind J . Planned preoperative radiation therapy in muscle invasive bladder cancer; results of a meta-analysis. Anticancer Res. 1998; 18(3B):1931-4. View

Dahm P, Gschwend J . Malignant non-urothelial neoplasms of the urinary bladder: a review. Eur Urol. 2003; 44(6):672-81. DOI: 10.1016/s0302-2838(03)00416-0. View

Chalasani V, Chin J, Izawa J . Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer. Can Urol Assoc J. 2009; 3(6 Suppl 4):S193-8. PMC: 2792446. DOI: 10.5489/cuaj.1195. View

Matsumoto S, Nishioka T, Akiyama T, Park Y, Kurita T, Ishikawa Y . [A case of squamous cell carcinoma of the bladder that was successfully treated with multidisciplinary therapies]. Hinyokika Kiyo. 2001; 47(1):43-6. View

Hayashi N, Asano K, Furuta A, Ikemoto I, Kishimoto K, Yamazaki H . [Invasive squamous cell carcinoma of the bladder: report of 18 cases and review of literature]. Nihon Hinyokika Gakkai Zasshi. 2004; 95(5):711-7. DOI: 10.5980/jpnjurol1989.95.711. View

Shokeir A . Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment. BJU Int. 2003; 93(2):216-20. DOI: 10.1111/j.1464-410x.2004.04588.x. View

10.

Holmang S, Lele S, Johansson S . Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome. J Urol. 2007; 178(1):51-6. DOI: 10.1016/j.juro.2007.03.033. View

11.

Rundle J, Hart A, McGeorge A, Smith J, Malcolm A, Smith P . Squamous cell carcinoma of bladder. A review of 114 patients. Br J Urol. 1982; 54(5):522-6. DOI: 10.1111/j.1464-410x.1982.tb13580.x. View

12.

Inui M, Fujita K, Ueda N, Takenaka I, Kakehi Y . [A case of regionally metastatic pure squamous cell carcinoma of the urinary bladder successfully treated with radical chemoradiotherapy]. Hinyokika Kiyo. 2002; 48(1):33-5. View

13.

Ploeg M, Aben K, Hulsbergen-van de Kaa C, Schoenberg M, Witjes J, Kiemeney L . Clinical epidemiology of nonurothelial bladder cancer: analysis of the Netherlands Cancer Registry. J Urol. 2010; 183(3):915-20. DOI: 10.1016/j.juro.2009.11.018. View

14.

Serretta V, Pomara G, Piazza F, Gange E . Pure squamous cell carcinoma of the bladder in western countries. Report on 19 consecutive cases. Eur Urol. 2000; 37(1):85-9. DOI: 10.1159/000020105. View

15.

Okamoto K, Okuno H, Fukuyama T, Itoyama M, Okamoto E . [A case of squamous cell carcinoma of the urinary bladder effectively responsive to combination chemotherapy]. Hinyokika Kiyo. 1991; 37(9):1045-8. View

16.

Blaveri E, Simko J, Korkola J, Brewer J, Baehner F, Mehta K . Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res. 2005; 11(11):4044-55. DOI: 10.1158/1078-0432.CCR-04-2409. View

17.

Johnson D, Schoenwald M, Ayala A, Miller L . Squamous cell carcinoma of the bladder. J Urol. 1976; 115(5):542-4. DOI: 10.1016/s0022-5347(17)59272-1. View

18.

Swanson D, Liles A, Zagars G . Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder. J Urol. 1990; 143(1):37-40. DOI: 10.1016/s0022-5347(17)39857-9. View

19.

Billis A, Schenka A, Ramos C, Carneiro L, Araujo V . Squamous and/or glandular differentiation in urothelial carcinoma: prevalence and significance in transurethral resections of the bladder. Int Urol Nephrol. 2002; 33(4):631-3. DOI: 10.1023/a:1020597611645. View

20.

Richie J, Waisman J, SKINNER D, Dretler S . Squamous carcinoma of the bladder: treatment by radical cystectomy. J Urol. 1976; 115(6):670-2. DOI: 10.1016/s0022-5347(17)59330-1. View